4-Bromo-5-methylpyrazolo[1,5-a]pyridine, 95.0%, 50mg

Ethyl 5-cyclopentyl-5-oxovalerate, 97.0%, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)pentanoic acid, 97%, 5g

4-Bromo-2,3-difluoropyridine, 95.0%, 1g

1-(4-(Trifluoromethoxy)phenyl)cyclopropane-1-carboxylic acid, 95%, 1g

tert-Butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate, 95.0%, 1g

2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid, 5mg

1-(4-(4-Iodo-1h-pyrazol-1-yl)phenyl)ethan-1-one, 95%, 100mg

H-Dl-Asp-Ome, 25g

DISUCCINIMIDYL GLUTARATE, 95.0%, 10g

Reaction vessel lid, clamp and ring Lid NS 29/32, 19/26, 14/23

TERT-BUTYL (3R)-3-[[(BENZYLOXY)CARBONYL]AMINO]PIPERIDINE-1-CARBOXYLATE, 97%, 500mg

5-fluoro-2-(1H-pyrazol-1-yl)benzaldehyde, 95.0%, 5g